Report overview
Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers.
This report contains market size and forecasts of T-cell engaging bsAbs Drugs in global, including the following market information:
Global T-cell engaging bsAbs Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global T-cell engaging bsAbs Drugs Market Sales, 2017-2022, 2023-2028, (Units)
Global top five T-cell engaging bsAbs Drugs companies in 2021 (%)
The global T-cell engaging bsAbs Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Blincyto Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T-cell engaging bsAbs Drugs include Amgen and Immunocore etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the T-cell engaging bsAbs Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-cell engaging bsAbs Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, by Type, 2021 (%)
Blincyto
Kimmtrak
Global T-cell engaging bsAbs Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, by Application, 2021 (%)
Hematological Cancers
Solid Tumors
Global T-cell engaging bsAbs Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global T-cell engaging bsAbs Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T-cell engaging bsAbs Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies T-cell engaging bsAbs Drugs revenues share in global market, 2021 (%)
Key companies T-cell engaging bsAbs Drugs sales in global market, 2017-2022 (Estimated), (Units)
Key companies T-cell engaging bsAbs Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Immunocore
